Clinical Trials Directory

Trials / Completed

CompletedNCT00214175

Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy

Status
Completed
Phase
Study type
Observational
Enrollment
44 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to evaluate and quantify the reproducibility of functional magnetic resonance imaging (fMRI) maps of the eloquent brain areas corresponding to specific neurological functions based on activation maps obtained with different thresholds in patients with benign and biopsy proven low-grade brain neoplasms. Another objective is to access the impairment in neurological function in image guided intracranial radiotherapy using neurocognitive assessment tools and to derive dose response curves relating the impairment in a particular neurological function to the FED received by the area of eloquent brain corresponding to it.

Conditions

Timeline

Start date
2004-06-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2005-09-21
Last updated
2012-02-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00214175. Inclusion in this directory is not an endorsement.

Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy (NCT00214175) · Clinical Trials Directory